New scan could spot cancer response sooner
NCT ID NCT04273555
Summary
This study aimed to test whether a combination PET/MRI scan could detect how well treatment is working in stage IV HER2-positive breast cancer patients earlier than current methods. Researchers planned to scan patients up to three times during their treatment to see if changes in the images could predict treatment success. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
Conditions
Explore the condition pages connected to this study.